PubRank

E Paul Wileyto

Author PubWeight™ 90.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med 2010 2.94
2 Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther 2006 2.49
3 Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med 2006 2.36
4 Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend 2009 2.15
5 Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 2007 2.11
6 Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006 1.93
7 Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav 2008 1.90
8 The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 2006 1.83
9 Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010 1.77
10 Applying a behavioral economic framework to understanding adolescent smoking. Psychol Addict Behav 2004 1.61
11 Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res 2004 1.59
12 Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 2004 1.50
13 The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change. Pediatrics 2011 1.48
14 Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol 2014 1.45
15 Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 2010 1.38
16 Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med 2006 1.34
17 Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol 2003 1.32
18 Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A 2011 1.29
19 Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 2005 1.25
20 Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res 2004 1.24
21 Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med 2005 1.23
22 Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry 2006 1.18
23 Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology 2010 1.17
24 Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy. Photochem Photobiol Sci 2009 1.17
25 Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002 1.13
26 Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol 2011 1.12
27 Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry 2006 1.12
28 Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 2008 1.12
29 Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. J Subst Abuse Treat 2007 1.08
30 Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol. BMJ Open 2014 1.07
31 Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res 2014 1.03
32 Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res 2004 1.03
33 Isoniazid-resistant tuberculous meningitis, United States, 1993-2005. Emerg Infect Dis 2011 1.01
34 Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Stat Med 2010 0.99
35 A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control 2010 0.99
36 Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res 2002 0.98
37 Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 2006 0.98
38 A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend 2008 0.98
39 Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav 2005 0.98
40 Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) 2004 0.97
41 Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol 2003 0.97
42 Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol 2013 0.96
43 Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate. Radiat Res 2010 0.95
44 Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine Tob Res 2011 0.95
45 Predictors of enrollment in a smoking cessation clinical trial after eligibility screening. J Natl Med Assoc 2009 0.94
46 Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med 2006 0.93
47 High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. J Biomed Opt 2005 0.93
48 Young adult smoking: what factors differentiate ex-smokers, smoking cessation treatment seekers and nontreatment seekers? Addict Behav 2009 0.93
49 Effect of photosensitizer dose on fluence rate responses to photodynamic therapy. Photochem Photobiol 2007 0.93
50 Digital image analysis of cigarette filter stains as an indicator of compensatory smoking. Cancer Epidemiol Biomarkers Prev 2006 0.92
51 Increase in anger symptoms after smoking cessation predicts relapse. Drug Alcohol Depend 2008 0.91
52 Nicotine abstinence-induced cerebral blood flow changes by genotype. Neurosci Lett 2008 0.91
53 Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results. Cancer 2014 0.91
54 Differences in cultural beliefs and values among African American and European American men with prostate cancer. Cancer Control 2007 0.89
55 Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007 0.88
56 Tumor vascular microenvironment determines responsiveness to photodynamic therapy. Cancer Res 2012 0.88
57 Intention to quit smoking: role of personal and family member cancer diagnosis. Health Educ Res 2010 0.88
58 The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence. J Addict Med 2013 0.87
59 Proactive recruitment predicts participant retention to end of treatment in a secondhand smoke reduction trial with low-income maternal smokers. Transl Behav Med 2011 0.86
60 Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model. Lasers Surg Med 2011 0.86
61 Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine Tob Res 2007 0.85
62 Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics 2011 0.84
63 Quantitative spatial analysis of hypoxia and vascular perfusion in tumor sections. Adv Exp Med Biol 2003 0.84
64 Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 2002 0.84
65 Multidrug resistant tuberculous meningitis in the United States, 1993-2005. J Infect 2011 0.84
66 Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol Biomarkers Prev 2005 0.84
67 Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology 2012 0.84
68 A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India. Nicotine Tob Res 2013 0.84
69 A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health Commun 2011 0.83
70 Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo. Nanomedicine (Lond) 2011 0.83
71 Brain activity and emotional processing in smokers treated with varenicline. Addict Biol 2011 0.83
72 High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial. Nicotine Tob Res 2012 0.83
73 μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology (Berl) 2012 0.82
74 First Use of Multiple Imputation with the National Tuberculosis Surveillance System. Epidemiol Res Int 2012 0.82
75 Is a cancer diagnosis a teachable moment for the patient's relative who smokes? Cancer Causes Control 2013 0.82
76 Adolescent environmental tobacco smoke exposure predicts academic achievement test failure. J Adolesc Health 2007 0.81
77 Individual differences in positivity offset and negativity bias: Gender-specific associations with two serotonin receptor genes. Pers Individ Dif 2013 0.80
78 Spiral computed tomography and lung cancer: science, the media, and public opinion. J Clin Oncol 2007 0.80
79 Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug Alcohol Depend 2013 0.79
80 Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction 2011 0.79
81 Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addict Behav 2011 0.76